{
    "code": "02013278",
    "許可證字號": "衛署藥輸字第013278號",
    "註銷狀態": "已註銷",
    "註銷日期": "102\/12\/16",
    "註銷理由": "未展延而逾期者",
    "有效日期": "98\/02\/04",
    "發證日期": "74\/02\/04",
    "許可證種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "通關簽審文件編號": "DHA00201327807",
    "中文品名": "倍司特克注射劑１公克",
    "英文品名": "BESTCALL INTRAVENOUS 1GM",
    "適應症": "葡萄球菌、鏈球菌、肺炎雙球菌、腦膜炎球菌及其他具有感受性細菌引起之感染症",
    "劑型": "270注射劑",
    "包裝": "小瓶",
    "藥品類別": "05限由醫師使用",
    "管制藥品分類級別": "",
    "主成分略述": "CEFMENOXIME (HEMIHYDROCHLORIDE)",
    "限制項目": [
        "02輸入"
    ],
    "申請商名稱": "1406701100  臺灣武田藥品工業股份有限公司",
    "申請商地址": "台北市南京東路三段２１７號７Ｆ",
    "主製造廠": {
        "製造廠名稱": "F260328000  TAKEDA PHARMACEUTICAL COMPANY LIMITED (HIKARI PLANT)",
        "製造廠廠址": "4270 TAKEDA MITSUI,HIKARI CITY,YAMAGUCHI,JAPAN",
        "製造廠公司地址": "",
        "製造廠國別": "JAPAN",
        "製程": ""
    },
    "CCC號列": "30042000319 人用醫藥製劑，含頭孢子菌類抗生素者Medicaments, containing cephalosporins, for human use",
    "藥理治療分類": "",
    "次製造廠": [
        {
            "製造廠名稱": "F260328300  TAKEDA PHARMACEUTICAL COMPANY LIMITED",
            "製造廠廠址": "1-1, DOSHOMACHI 4-CHOME, CHUO-KU, OSAKA, JAPAN.",
            "製造廠公司地址": "",
            "製造廠國別": "JAPAN",
            "製程": "許可證持有者"
        }
    ],
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "0812692610",
            "成分名稱": "CEFMENOXIME (HEMIHYDROCHLORIDE)",
            "含量描述": "(1.035GM) 1.0",
            "含量": "",
            "單位": "GM"
        }
    ],
    "仿單外盒": [
        {
            "title": "仿單 020132780001.doc",
            "url": "http:\/\/www.fda.gov.tw\/MLMS\/(S(knoy1cz5iwyfatvvguaez0re))\/ShowFile.aspx?LicId=02013278&Seq=001&Type=9"
        }
    ]
}